Medical cost-offset following treatment referral for alcohol and other drug use disorders in a group model HMO.
The purpose of this study was to determine whether specialty alcohol and other drug (AOD) treatment is associated with reduced subsequent medical care costs. AOD treatment costs and medical costs in a group model health maintenance organization (HMO) were collected for up to 6 years on 1,472 HMO members who were recommended for specialty AOD treatment, and on 738 members without AOD diagnoses or treatment. Addiction Severity Index measures were also obtained from a sample of 293 of those recommended for treatment. Changes in medical costs did not differ between treatment and comparison groups. Nor did individuals with improved treatment outcomes have greater reductions in medical costs. AOD treatment costs were not inversely related to subsequent medical costs, except for a subgroup with recent AOD treatment. In the interviewed sample, better treatment outcomes did not predict lower subsequent medical costs. Multiple treatment episodes may hold promise for producing cost-offsets.
Polen
Michael R
MR
Center for Health Research, Kaiser Permanente Northwest, 3800 N. Interstate Avenue, Portland, OR 97227, USA. michael.polen@kpchr.org
Freeborn
Donald K
DK
Lynch
Frances L
FL
Mullooly
John P
JP
Dickinson
Daniel M
DM
D000328:Adult; D003363:Cost Control; D005260:Female; D005102:Health Expenditures; D006279:Health Maintenance Organizations; D006801:Humans; D007407:Interviews as Topic; D008297:Male; D008875:Middle Aged; D009922:Oregon; D012017:Referral and Consultation; D019966:Substance-Related Disorders / Q000628:therapy*; D016896:Treatment Outcome